LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Hany Ahmed Mostafa M. Omar

Hany Ahmed Mostafa M. Omar

LiveDNA ID: 20.5757
33 Publications
0 Editorial Roles
0 Projects

About

Professional Summary

Dr. Hany A. Omar is currently working as Assistant Professor of Pharmacology and Molecular Therapeutics, College of Clinical Pharmacy, Taif University (TU), KSA. He obtained his PhD in Molecular Pharmacology from The Ohio State University, USA. He also worked as Clinical Pharmacist at the National Cancer Institute, Assistant lecturer, Lecturer and Graduate Research Associate and Instructor of Pharmacology & Toxicology at Cairo University, Beni-Suef Campus, Egypt, Graduate Research Associate, Teaching Assistant, and Post-Doctoral Fellow at The Ohio State University (OSU), Columbus, OH, USA. He has published 15 articles in journals and 12 scientific abstract and poster presentations. Dr. Hany A Omar received number of honors includes, The winner of 107,000 SR grant for a research proposal from Taif University Vice-Presidency for Graduate Studies and Research, The winner of 31,000 LE Scientific Publications Awards for the best published research article, The National Institutes of Health (NIH) travel award, American Association of Cancer Research (AACR) award, and Invited Member of the National Honor Society of Phi Kappa Phi. His area of professional interest includes Molecular Mechanisms of Anticancer Drugs, Molecular Pharmacology as a basis for Drugs Development, Molecular Pharmacology as a basis for Cardiovascular Drugs Development, Oxidative Stress and Antioxidants Implication in the Path Physiology of many Clinical Disorders. He is professional member of different societies such as European Association for Cancer Research (EACR), American Association for Cancer Research (AACR), The Egyptian Society of Pharmacology and Experimental Therapeutics, The American Association of Pharmaceutical Scientists, The Honor Society of Phi Kappa Phi, American Society Clinical Pharmacology Therapeutics, American Society for Biochemistry and Molecular Biology, The General Syndicate of Pharmacists in Egypt, and The Egyptian Association of Pharmacists. He is also serving as invited reviewer in many journals, and Associate Editor for Beni-Suef University Journal of Applied Sciences. He is also working as member of the board of trustees of Egyptian Student Association in North America (ESANA).

Education

Academic Background
  • PostDoc Fellow The Ohio State University, USA Cancer Research | Completed: 2011

Publications (33)

Selected Scholarly Contributions
Angiotensin inhibitors potentiate the hypoglycemic and antioxidant effects of gliclazide in rats.
AbdEllraheim, M.A., A.M. AboYoussef, H.A. Omar and H.A. AbdEllatif,
Int. J. Pharm. Sci. Rev. Res., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
Nebivolol and chrysin protect the liver against ischemia/reperfusion-induced injury in rats.
Mizar, S.M., H.A. Omar, G.A. El Sherbiny and M.A. El-moselhy,
Beni-Suef Univ. J. Basic Appl. Sci., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
6-Shogaol induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms.
Wu, J.J., H.A. Omar, Y.R. Lee, Y.N. Teng and P.S. Chen et al.,
Eur. J. Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
Glutamyl cysteine dipeptide suppresses ferritin expression and alleviates liver injury in iron-overload rat model.
Salama, S.A., M.S. Al-Harbi, M.S. Abdel-Bakky and H.A. Omar,
Biochimie, | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
Trimetazidine, sildenafil and coenzyme Q10 protect rats' kidney from ischemia/reperfusion injury.
Azouz, A.A., H.A. Omar, A.M. Abo-yousef, G.A. El-Sherbiny and H.A. Abdel-latif,
Br. J. Pharmacol. Toxicol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
Design and synthesis of certain novel arylidene thiazolidinone derivatives as anticancer agents.
Abdellatif, K.R., E.K. Abdelall, M.A. Abdelgawad, M.M. Abdelhakeem and H.A. Omar,
Der Pharma Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2015
Synthesis, characterization and biological evaluation of novel 4'-fluoro-2'-hydroxy-chalcone derivatives as antioxidant, anti-inflammatory and analgesic agents.
Abdellatif, K.R., H.A. Elshemy, S.A. Salama and H.A. Omar,
J. Enzyme Inhib. Med. Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Potential targets of energy restriction mimetic agents in cancer cells.
Omar, H.A., M.F. Tolba and M.M. Saber-Ayad,
Future Oncol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats.
Elhemely, M.A., H.A. Omar, A.A. Ain-Shoka, H.A. Abd El-Latif, A.M. Abo-Youssef and G.A. El Sherbiny,
Beni-Suef Univ. J. Basic Applied Sci., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents.
Abdelazeem, A.H., A.M. Gouda, H.A. Omar and M.F. Tolba,
Bioorg. Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
Abdelazeem, A.H., S.A. Abdelatef, M.T. El-Saadi, H.A. Omar and S.I. Khan et al.,
Eur. J. Pharm. Sci., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Cymbopogon proximus extract decreases L-NAME-induced hypertension in rats.
El-Nezhawy, A.O.H., I.A. Maghrabi, K.M. Mohamed and H.A. Omar,
Int. J. Pharm. Sci. Rev. Res., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Camel's milk ameliorates TNBS-induced colitis in rats via downregulation of inflammatory cytokines and oxidative stress.
Arab, H.H., S.A. Salama, A.H. Eid, H.A. Omar and E.S.A. Arafa et al.,
Food Chem. Toxicol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a Novel Akt/NF-κB signalling inhibitor.
Omar, H.A., E.S.A. Arafa, I.A. Maghrabi and J.R. Weng,
Basic Clin. Pharmacol. Toxicol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro.
Arafa, E.A., A.H. Abdelazeem, H.H. Arab and H.A. Omar,
Acta Pharmacol. Sin., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Nicotine mediates hypochlorous acid-induced nuclear protein damage in mammalian cells.
Salama, S.A., H.H. Arab, H.A. Omar, I.A. Maghrabi and R.M. Snapka,
Inflammation, | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Modulation of cyclins, p53 and Mitogen-Activated Protein Kinases signaling in breast cancer cell lines by 4-(3,4,5-Trimethoxyphenoxy)benzoic acid.
Lee, K.H., W.Y. Ho, S.J. Wu, H.A. Omar and P.J. Huang et al.,
Int. J. Mol. Sci., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
Iron supplementation at high altitudes induces inflammation and oxidative injury to lung tissues in rats.
Salama, S.A., H.A. Omar, I.A. Maghrabi, M.S. AlSaeed and A.E. EL-Tarras,
Toxicol. Appl. Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2014
OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar, H.A., S.A. Arafa, S.A. Salama and J.R. Weng,
Toxicol. Applied Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar, H.A., E.S.A. Arafa, S.A. Salama, H.H. Arab and C.H. Wu et al.,
Toxicol. Appl. Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.
Abdellatif, K.R.A., A. Belal and H.A. Omar,
Bioorg. Med. Chem. Lett., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Synthesis, anti-breast cancer activity, and molecular modeling of some benzothiazole and benzoxazole derivatives.
Abdelgawad, M.A., A. Belal, H.A. Omar, L. Hegazy and M.E. Rateb,
Arch. Pharm., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Antitumor effects of energy restriction-mimetic agents: Thiazolidinediones.
Omar, H.A., S.A. Salama, E.S.A. Arafa and J.R. Weng,
Biol. Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Synthesis of novel substituted 4H-chromenes and their antioxidant screening.
Abdelgawad, M.A., H.A.H. Elshemy, K.R.A. Abdellatif and H.A. Omar,
J. Chem. Pharm. Res., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
El-Nezhawy, A.O.H., A.R. Biuomy, F.S. Hassan, A.K. Ismaiel and H.A. Omar,
Bioorg. Med. Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2013
Energy restriction: Stepping stones towards cancer therapy.
Omar, H.A., L. Berman-Booty and J.R. Weng,
Future Oncol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2012
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
Omar, H.A., C.C. Chou, L.D. Berman-Booty, Y. Ma and J.H. Hung et al.,
Hepatology, | Journal Article
Self Hany Ahmed Mostafa M. Omar
2011
Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
Bai, L.Y., H.A. Omar, C.F. Chiu, Z.P. Chi, J.L. Hu and J.R. Weng,
Cancer Chemother. Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2011
Energy restriction as an antitumor target.
Omar, H.A., L. Berman-Booty, S.K. Kulp and C.S. Chen,
Future Oncol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2010
Pharmacological exploitation of indole-3-carbinol to develop potent antitumor agents.
Weng, J.R., H.A. Omar, S.K. Kulp and C.S. Chen,
Mini-Rev. Med. Chem., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2010
A novel indole-3-carbinol derivative inhibits the growth of human oral squamous cell carcinoma in vitro.
Weng, J.R., L.Y. Bai, H.A. Omar, A.M. Sargeant and C.T. Yeh et al.,
Oral Oncol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2010
OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-κB pathway and stress response signaling.
Weng, J.R., C.H. Tsai, H.A. Omar, A.M. Sargeant and D. Wang et al.,
Carcinogenesis, | Journal Article
Self Hany Ahmed Mostafa M. Omar
2009
Targeting of the Akt-nuclear factor-κB signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.
Omar, H.A., A.M. Sargeant, J.R. Weng, D. Wang and S.K. Kulp et al.,
Mol. Pharmacol., | Journal Article
Self Hany Ahmed Mostafa M. Omar
2009